AXIM BIOTECHNOLOGIES, INC. Quarterly Debt-to-equity in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Axim Biotechnologies, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q2 2024.
  • Axim Biotechnologies, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -152 %, a 9.47% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -152 +15.9 +9.47% Jun 30, 2024
Q1 2024 -153 +37.3 +19.6% Mar 31, 2024
Q4 2023 -156 +56 +26.4% Dec 31, 2023
Q3 2023 -162 +77.7 +32.4% Sep 30, 2023
Q2 2023 -168 +534 +76.1% Jun 30, 2023
Q1 2023 -190 +45.6K +99.6% Mar 31, 2023
Q4 2022 -212 -940 -129% Dec 31, 2022
Q3 2022 -240 -671 -156% Sep 30, 2022
Q2 2022 -702 -1.29K -219% Jun 30, 2022
Q1 2022 -45.8K -46.4K -7647% Mar 31, 2022
Q4 2021 728 -184 -20.2% Dec 31, 2021
Q3 2021 431 +1.46K Sep 30, 2021
Q2 2021 591 Jun 30, 2021
Q1 2021 606 Mar 31, 2021
Q4 2020 912 Dec 31, 2020
Q3 2020 -1.03K Sep 30, 2020
Q1 2017 -135 +128 +48.6% Mar 31, 2017
Q4 2016 -135 Dec 31, 2016
Q3 2016 -135 Sep 30, 2016
Q2 2016 -154 Jun 30, 2016
Q1 2016 -263 Mar 31, 2016
Q3 2012 593 Sep 30, 2012
Q2 2012 525 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.